Events
GRASP brings patients and researchers together for small-group conversations that make cancer science more accessible, collaborative, and deeply informed by patient experience.
Poster Walkthroughs are virtual small group sessions where advocates and researchers discuss posters from cancer conferences.
ESMO: Group 3D: Combining Targeted Therapies & Immunotherapy in Metastatic Breast Cancer
Tuesday, November 3, 2026
8:00–9:30 PM CET/Madrid
2:00–3:30 PM ET/New York
The ESMO Congress 2026 is a leading global oncology event showcasing the latest advances in cancer research and treatment. GRASP provides a unique opportunity for advocates and clinical researchers to join the conversation through Poster Walkthroughs.
Register Below
This ESMO26 Poster Walkthrough group will explore key findings from the following posters:
Poster #4645P: Exposure Response (E-R) Analysis of First-Line (1L) Sacituzumab Govitecan (SG) Plus Pembrolizumab (Pembro) for Participants (pts) With Metastatic Triple-Negative Breast Cancer (mTNBC) From the ASCENT-04 Study
Poster #1771P: Trastuzumab deruxtecan (T-DXd) + pembrolizumab (PEM) in previously treated human epidermal growth factor receptor 2 (HER2)–expressing advanced or metastatic breast cancer (mBC): primary analyses of the breast cohorts from the open-label, multicenter, phase 1b study DS8201-A-U106
Keywords: HER2+ Breast Cancer; Triple Negative Breast Cancer; ADCs; Immunotherapy; Clinical trials
Patient Advocate
Advocate Mentor
Scientist
Shadow Mentor
Shadow Scientist
